David J. Lozano, MD
NPI 1518915305ActiveIndividual· Pediatrics, Pediatric Pulmonology· Dothan, AL
Pediatrics, Pediatric Pulmonology (MD) in Dothan, Alabama, trained at University of Texas Medical Branch at Galveston (class of 1998). Part D covered 25 prescriptions written in 2024, 52% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 9 companies reporting payments in 2025, $1,203 in all, mostly food and beverage.
Overview
| NPI | 1518915305 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | May 4, 2006 |
| Last updated in NPPES | May 14, 2020 |
| Certified by provider | May 14, 2020 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Pediatrics, Pediatric Pulmonology Primary | 2080P0214X | MD.24011 | AL |
| Pediatrics | 208000000X | MD.24011 | AL |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Pulmonary Disease (AL) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 25 · 31 30-day fills |
|---|---|
| Total drug cost | $7,035 |
| Generic share | 52% of claims |
Education and affiliations
| Medical school | University of Texas Medical Branch at Galveston |
|---|---|
| Graduation year | 1998 |
| Medicare specialty | Pulmonary Disease |
| Secondary specialties | Pediatric Medicine, Sleep Medicine |
Medical group
- Dothan Pediatric Clinic, P. A.Dothan, AL · 10 clinicians
Industry payments (Open Payments)
- 2025$1,203 · 50 payments from 9 companies
- 2024$1,362 · 44 payments from 10 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $363.59 | 15 |
| Jazz Pharmaceuticals Inc. | $314.93 | 10 |
| Amgen Inc. | $197.59 | 13 |
| Regeneron Healthcare Solutions, Inc. | $80.08 | 4 |
| Alcresta Therapeutics, Inc. | $76.00 | 1 |
What the 2025 payments were for
- Food and Beverage$1,069 · 48 payments
- Education$133.99 · 2 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records